[Current trends in the treatment of mycotic infections].
Several new drugs have recently been developed which will contribute to improve control of mycoses. Especially oral broad spectrum antifungals seem to open a new era of antimycotic therapy. As many mycoses are based on limited deficiencies of the host's defense systems, immunostimulating therapy becomes increasingly important, but is still in the beginning of its development. World-wide programmes stimulated by WHO, ISHAM and other international Medical Associations should help do distribute the achievements of pharmaceutical research to regions of greatest need.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use*; D006801:Humans; D009181:Mycoses / Q000188:drug therapy* / Q000276:immunology / Q000628:therapy; D014944:World Health Organization
D000276:Adjuvants, Immunologic; D000935:Antifungal Agents
Gegenwärtige Tendenzen in der Behandlung mykotischer Infektionen.